Sango-an, Jezzel B.

HRN: 27-49-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2026
CEFUROXIME 1.5GM (VIAL)
08/09/2026
08/15/2026
IV
1.5g
Q8
UTI
Remove - Pending Acceptance
08/11/2026
METRONIDAZOLE 500MG (TAB)
08/11/2026
08/18/2026
ORAL
500
TID
Amoebiasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: